BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8679262)

  • 1. Immunoscintigraphy: Importance for researchers and patients.
    Britton KE; Granowska M
    Acta Oncol; 1996; 35(3):313-7. PubMed ID: 8679262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoscintigraphy in inflammatory and malignant diseases. anti-leukocyte and anti-tumor antibodies].
    Kramer W; Baum RP; Hör G; Jonas D
    Urologe A; 1993 Mar; 32(2):108-14. PubMed ID: 8475608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour imaging with radiolabelled monoclonal antibodies.
    Britton KE
    Wien Klin Wochenschr; 1994; 106(2):35-6. PubMed ID: 8146993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoscintigraphy in oncology].
    Vuillez JP
    Rev Med Interne; 1995; 16(11):833-42. PubMed ID: 8570940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscintigraphy of tumours using 99Tcm-labelled monoclonal antibodies: a review.
    Reilly RM
    Nucl Med Commun; 1993 May; 14(5):347-59. PubMed ID: 8510874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
    Oriuchi N
    Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating antigen: bad or good for immunoscintigraphy?
    Pimm MV
    Nucl Med Biol; 1995 Feb; 22(2):137-45. PubMed ID: 7767306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
    Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
    Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of clinical radioimmunodetection of human tumors.
    Larson SM; Divgi CR; Scott AM
    Cancer; 1994 Feb; 73(3 Suppl):832-5. PubMed ID: 8306267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer.
    Stocchi L; Nelson H
    Dis Colon Rectum; 1998 Feb; 41(2):232-50. PubMed ID: 9556250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabelled monoclonal antibodies in clinical and surgical oncology: a review.
    Biassoni L; D'Andrea V; Biancari F; Santoni F; Dibra A; De Antoni E
    Panminerva Med; 1997 Mar; 39(1):46-52. PubMed ID: 9175421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoscintigraphy with a 99Tcm-labelled anti-granulocyte monoclonal antibody in patients with human immunodeficiency virus infection and AIDS.
    Prvulovich EM; Miller RF; Costa DC; Severn A; Corbett E; Bomanji J; Becker WS; Ell PJ
    Nucl Med Commun; 1995 Oct; 16(10):838-45. PubMed ID: 8570114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoscintigraphy of tumors in clinical practice].
    Dvorák P
    Cas Lek Cesk; 1988 Dec; 127(49):1508-11. PubMed ID: 3219708
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
    Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
    Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma].
    Rentsch M; Cerny T; Richner J; Brunner KW; Rösler H; Nachbur B
    Helv Chir Acta; 1989 Jun; 56(1-2):11-3. PubMed ID: 2777587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58.
    Yao YF; Yang Z; Li ZF; Gu J
    World J Gastroenterol; 2007 Mar; 13(12):1841-6. PubMed ID: 17465478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical results of immunoscintigraphy and radioimmunotherapy].
    Baum RP; Lorenz M; Senekowitsch R; Albrecht M; Hör G
    Nuklearmedizin; 1987 Apr; 26(2):68-78. PubMed ID: 3588320
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunoscintigraphy. Development, current status and prospects].
    Baum RP; Hör G
    Nuklearmedizin; 1986 Oct; 25(5):157-61. PubMed ID: 3491975
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunoscintigraphy of melanoma using radiolabelled antibodies: pilot, prospective studies and Italian multicenter clinical trials.
    Buraggi GL; Gasparini M
    Int J Rad Appl Instrum B; 1989; 16(6):629-32. PubMed ID: 2691456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of non-small cell lung cancer using HMFG1-99mTc monoclonal antibodies.
    Pavlović S; Jovanović D; Radosavljević G; Kozarević N; Nastić-Mirić D; Rebić R; Bosnjáković V; Epenetos A
    Med Pregl; 1993; 46 Suppl 1():26-8. PubMed ID: 8569597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.